SHU Baojun, LEI Shuhong, CHEN Yu, ZHU Jiali. Ranibizumab versus compacept in the treatment of patients with wet age-related macular degeneration[J]. Journal of Clinical Medicine in Practice, 2018, (17): 93-95,98. DOI: 10.7619/jcmp.201817027
Citation:
|
SHU Baojun, LEI Shuhong, CHEN Yu, ZHU Jiali. Ranibizumab versus compacept in the treatment of patients with wet age-related macular degeneration[J]. Journal of Clinical Medicine in Practice, 2018, (17): 93-95,98. DOI: 10.7619/jcmp.201817027
|
SHU Baojun, LEI Shuhong, CHEN Yu, ZHU Jiali. Ranibizumab versus compacept in the treatment of patients with wet age-related macular degeneration[J]. Journal of Clinical Medicine in Practice, 2018, (17): 93-95,98. DOI: 10.7619/jcmp.201817027
Citation:
|
SHU Baojun, LEI Shuhong, CHEN Yu, ZHU Jiali. Ranibizumab versus compacept in the treatment of patients with wet age-related macular degeneration[J]. Journal of Clinical Medicine in Practice, 2018, (17): 93-95,98. DOI: 10.7619/jcmp.201817027
|